These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Dopamine transporter density in the basal ganglia in obsessive-compulsive disorder, measured with [123I]IPT SPECT before and after treatment with serotonin reuptake inhibitors. Kim CH; Cheon KA; Koo MS; Ryu YH; Lee JD; Chang JW; Lee HS Neuropsychobiology; 2007; 55(3-4):156-62. PubMed ID: 17657168 [TBL] [Abstract][Full Text] [Related]
14. [Pharmacological treatments for obsessive-compulsive disorder and the serotonin-dopamine hypothesis]. Okamoto Y Seishin Shinkeigaku Zasshi; 2011; 113(1):36-44. PubMed ID: 21404630 [TBL] [Abstract][Full Text] [Related]
15. Functional connectivity of the raphe nucleus as a predictor of the response to selective serotonin reuptake inhibitors in obsessive-compulsive disorder. Kim M; Kwak S; Yoon YB; Kwak YB; Kim T; Cho KIK; Lee TY; Kwon JS Neuropsychopharmacology; 2019 Nov; 44(12):2073-2081. PubMed ID: 31189178 [TBL] [Abstract][Full Text] [Related]
16. Functional disruption in prefrontal-striatal network in obsessive-compulsive disorder. Sha Z; Versace A; Edmiston EK; Fournier J; Graur S; Greenberg T; Santos JPL; Chase HW; Stiffler RS; Bonar L; Hudak R; Yendiki A; Greenberg BD; Rasmussen S; Liu H; Quirk G; Haber S; Phillips ML Psychiatry Res Neuroimaging; 2020 Jun; 300():111081. PubMed ID: 32344156 [TBL] [Abstract][Full Text] [Related]
17. Altered anatomical connections of associative and limbic cortico-basal-ganglia circuits in obsessive-compulsive disorder. Haynes WIA; Clair AH; Fernandez-Vidal S; Gholipour B; Morgiève M; Mallet L Eur Psychiatry; 2018 Jun; 51():1-8. PubMed ID: 29514116 [TBL] [Abstract][Full Text] [Related]
18. Obsessive-compulsive behaviour: a disorder of decision-making. Sachdev PS; Malhi GS Aust N Z J Psychiatry; 2005 Sep; 39(9):757-63. PubMed ID: 16168033 [TBL] [Abstract][Full Text] [Related]